Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 17Unknown 4Terminated 4Recruiting 4Not yet recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 58Colonic Neoplasms 24Rectal Neoplasms 22Neoplasms 19Pancreatic Neoplasms 18Neoplasm Metastasis 17Esophageal Neoplasms 9Stomach Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Sarcoma 6Small Cell Lung Carcinoma 5Lung Neoplasms 5Glioma 5Glioblastoma 5Brain Neoplasms 5Neuroblastoma 4Gliosarcoma 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Renal Cell 4Melanoma 3Intestinal Neoplasms 3Gastrointestinal Neoplasms 3Breast Neoplasms 3Adenocarcinoma Of Esophagus 3Adenocarcinoma 3Sarcoma, Ewing 2Recurrence 2Rectal Diseases 2Ovarian Neoplasms 2Oligodendroglioma 2

Interventions

Cisplatin 8Radiotherapy 7Fluorouracil 6Neoadjuvant Therapy 4Irinotecan 4pembrolizumab 3Paclitaxel 3Gefitinib 3Carboplatin 3toripalimab 2spartalizumab 2Oxaliplatin 2Nivolumab 2Esophagectomy 2Docetaxel 2vandetanib 1tislelizumab 1sitravatinib 1ribociclib 1oblimersen 1nazartinib 1liposomal doxorubicin 1apatinib 1Surgical Procedures, Operative 1SGN-LIV1A 1Proton Therapy 1Pemetrexed 1Panitumumab 1Nutritional Support 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Esophageal Squamous Cell Carcinoma × Irinotecan × Clear all
NCT05461794 2025-06-13

Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma

BeiGene

Phase 2 Terminated
96 enrolled 17 charts
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03251417 2023-02-01

Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma

Peking University

Phase 2 Terminated
11 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00109850 2015-11-18

S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

SWOG Cancer Research Network

Phase 2 Terminated
22 enrolled 9 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00290719 2014-05-09

Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

University of California, San Francisco

Phase 1 Terminated
6 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡